Amano, Y.; Honda, H.; Nukada, Y.; Ikeda, N.; Yamane, M.; Nakano, K.; Kameyama, A.; Morita, O.
Safety Pharmacological Evaluation of the Coffee Component, Caffeoylquinic Acid, and Its Metabolites, Using Ex Vivo and In Vitro Profiling Assays. Pharmaceuticals 2019, 12, 110.
https://doi.org/10.3390/ph12030110
AMA Style
Amano Y, Honda H, Nukada Y, Ikeda N, Yamane M, Nakano K, Kameyama A, Morita O.
Safety Pharmacological Evaluation of the Coffee Component, Caffeoylquinic Acid, and Its Metabolites, Using Ex Vivo and In Vitro Profiling Assays. Pharmaceuticals. 2019; 12(3):110.
https://doi.org/10.3390/ph12030110
Chicago/Turabian Style
Amano, Yuto, Hiroshi Honda, Yuko Nukada, Naohiro Ikeda, Masayuki Yamane, Koji Nakano, Akiyo Kameyama, and Osamu Morita.
2019. "Safety Pharmacological Evaluation of the Coffee Component, Caffeoylquinic Acid, and Its Metabolites, Using Ex Vivo and In Vitro Profiling Assays" Pharmaceuticals 12, no. 3: 110.
https://doi.org/10.3390/ph12030110
APA Style
Amano, Y., Honda, H., Nukada, Y., Ikeda, N., Yamane, M., Nakano, K., Kameyama, A., & Morita, O.
(2019). Safety Pharmacological Evaluation of the Coffee Component, Caffeoylquinic Acid, and Its Metabolites, Using Ex Vivo and In Vitro Profiling Assays. Pharmaceuticals, 12(3), 110.
https://doi.org/10.3390/ph12030110